Godfrey Financial Associates’s Amicus Therapeutics FOLD Stock Holding History

Godfrey Financial Associates’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-183	Closed	-$2.65K	–	1103
2026 Q1	$2.65K	Buy	183 +62	+51%	+$889	﹤0.01%	608
2025 Q4	$1.72K	Buy	+121	New	+$1.19K	﹤0.01%	651

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Godfrey Financial Associates's FOLD Position: Q2 2026 in Review

Godfrey Financial Associates sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 183 shares — an estimated $2.65K sold.

Godfrey Financial Associates first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $2.65K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Godfrey Financial Associates reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Godfrey Financial Associates sold 183 Amicus Therapeutics shares in Q2 2026, an estimated $2.65K.
Godfrey Financial Associates first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
Godfrey Financial Associates's Amicus Therapeutics position peaked at $2.65K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Godfrey Financial Associates's 13F filing for Q2 2026, filed 11 Aug 2026.